Elekta (OTCMKTS:EKTAY) Sees Strong Trading Volume – Here’s Why

Elekta AB (OTCMKTS:EKTAY) saw strong trading volume on Thursday . 6,765 shares changed hands during mid-day trading, an increase of 125% from the previous session’s volume of 3,000 shares.The stock last traded at $5.76 and had previously closed at $5.83.

Analyst Ratings Changes

Separately, Zacks Research upgraded shares of Elekta from a “strong sell” rating to a “hold” rating in a report on Tuesday, July 28th. One research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Elekta has a consensus rating of “Reduce”.

Elekta Price Performance

The company has a market cap of $2.12 billion, a price-to-earnings ratio of -36.00 and a beta of 1.01. The company has a fifty day simple moving average of $5.14 and a two-hundred day simple moving average of $5.72. The company has a quick ratio of 0.68, a current ratio of 0.87 and a debt-to-equity ratio of 0.47.

Elekta (OTCMKTS:EKTAY) last announced its quarterly earnings data on Thursday, May 28th. The company reported $0.06 earnings per share (EPS) for the quarter. The business had revenue of $521.00 million for the quarter. Elekta had a negative net margin of 3.32% and a positive return on equity of 11.11%. On average, equities research analysts anticipate that Elekta AB will post 0.43 earnings per share for the current fiscal year.

About Elekta

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.